NDC 0781-8201 – Cladribine
Cladribine 10 mg/1 · Tablet · Oral
Product NDC0781-8201
Product details
- Brand name
- Cladribine
- Generic name
- Cladribine
- Labeler
- Sandoz Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA215547
- Marketed since
- April 29, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Purine Antimetabolite
Active ingredients
- Cladribine 10 mg/1
Package NDC codes (7)
| Package NDC | Description | Since |
|---|---|---|
| 0781-8201-37 | 9 TABLET in 1 CARTON (0781-8201-37) | Apr 29, 2026 |
| 0781-8201-51 | 5 TABLET in 1 CARTON (0781-8201-51) | Apr 29, 2026 |
| 0781-8201-68 | 6 TABLET in 1 CARTON (0781-8201-68) | Apr 29, 2026 |
| 0781-8201-71 | 7 TABLET in 1 CARTON (0781-8201-71) | Apr 29, 2026 |
| 0781-8201-80 | 10 TABLET in 1 CARTON (0781-8201-80) | Apr 29, 2026 |
| 0781-8201-85 | 8 TABLET in 1 CARTON (0781-8201-85) | Apr 29, 2026 |
| 0781-8201-94 | 4 TABLET in 1 CARTON (0781-8201-94) | Apr 29, 2026 |
Other Cladribine products
- 60505-4791 Cladribine 10 mg/1 · Tablet · Apotex Corp.
- 62049-286 Cladribine 10 mg/1 · Tablet · Genvion Corporation
- 63323-140 Cladribine 1 mg/mL · Injection · Fresenius Kabi USA, LLC
- 0143-9871 Cladribine 1 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 42658-010 Cladribine 1 mg/mL · Injection, Solution · Hisun Pharmaceuticals USA, Inc.